Remove Bone Scan Remove Clinic Remove Healthcare Remove Pharmaceutical
article thumbnail

FDA Accepts Telix NDA for New Prostate Cancer Imaging Agent

Imaging Technology

mtaschetta-millane Wed, 07/24/2024 - 11:17 July 24, 2024 — Telix Pharmaceuticals Limited announced that the United States (U.S.) Through this NDA, Telix's objective is to further enhance patient access to PSMA-PET imaging and the clinical benefits of 68Ga imaging to underserved populations across the U.S., Accessed May 2024. [7]

Imaging 105
article thumbnail

AuntMinnie 2007: Gadolinium: A 'necessary factor' in the development of NSF?

AuntMinnie

But grappling with NSF after the fact may be the least troubling issue as healthcare experts scramble to figure out why some patients develop NSF -- and what they can do to prevent NSF from occurring in the first place. Short of a kidney transplant, NSF is difficult to manage. Giles, U.K. Omniscan binds least strongly."

Disease 116